INVENTISBIO
InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
INVENTISBIO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.inventisbio.com
Total Employee:
1+
Status:
Active
Total Funding:
247 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Wordpress Plugins Nginx Euro Microsoft Exchange Online
Similar Organizations
Genevide
Genevide is a biotech company that specializes in gene research and development.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Dyee Capital
Dyee Capital investment in Series D - InventisBio
Janchor Partners
Janchor Partners investment in Series D - InventisBio
Qiming Venture Partners
Qiming Venture Partners investment in Series D - InventisBio
E Fund Management Co.,LTD.
E Fund Management Co.,LTD. investment in Series D - InventisBio
Pudong Innotek
Pudong Innotek investment in Series D - InventisBio
Matrix Partners China
Matrix Partners China investment in Series D - InventisBio
Lilly Asia Ventures
Lilly Asia Ventures investment in Series D - InventisBio
GL Ventures
GL Ventures investment in Series D - InventisBio
CMB International Capital Corporation
CMB International Capital Corporation investment in Series D - InventisBio
Advantech Capital
Advantech Capital investment in Series D - InventisBio
Official Site Inspections
http://www.inventisbio.com
- Host name: 139.224.229.15
- IP address: 139.224.229.15
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
